Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form

被引:103
作者
Bourquin, J
Schmidli, H
van Hoogevest, P
Leuenberger, H
机构
[1] Novartis Pharma AG, Pharmaceut & Analyt Dev, CH-4002 Basel, Switzerland
[2] Novartis Serv AG, Math Applicat, Basel, Switzerland
[3] Univ Basel, Coll Pharm, Basel, Switzerland
关键词
Artificial Neural Networks (ANNs); comparison of modelling techniques; associating networks; Response Surface Methodology (RSM); non-linear relationships; tablet compression study; pharmaceutical technology;
D O I
10.1016/S0928-0987(97)10028-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Artificial Neural Networks (ANN) methodology was used to assess experimental data from a tablet compression study showing highly non-linear relationships (i.e. measurements of ejection forces) and compared to classical modelling technique (i.e. Response Surface Methodology, RSM). These kinds of relationships are known to be difficult to model using classical methods. The aim of this investigation was to quantitatively describe the achieved degree of data fitting and predicting abilities of the developed models. The comparison between the ANN and RSM was carried out both graphically and numerically. For comparing the goodness of fit, all data were used, whereas for the goodness of prediction the data were split into a learning and a validation data set. Better results were achieved for the model using ANN methodology with regard to data fitting and predicting ability. All determined ejection properties were mainly influenced by the concentration of magnesium stearate and silica aerogel, whereas the other factors showed very much lower effects. Important relationships could be recognised from the ANN model only, whereas the RSM model ignored them. The ANN methodology represents a useful alternative to classical modelling techniques when applied to variable data sets presenting non-linear relationships. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:5 / 16
页数:12
相关论文
共 17 条
[1]  
[Anonymous], P 1 IEEE INT JOINT C
[2]  
Bourquin J, 1997, Pharm Dev Technol, V2, P111, DOI 10.3109/10837459709022616
[3]  
Bourquin J, 1997, Pharm Dev Technol, V2, P95, DOI 10.3109/10837459709022615
[4]  
Bozic D. Z., 1996, FARMACEVTSKI VESTNIK, V47, P185
[5]  
*CIB GEIG, 1995, STAVEX EXP SYST STAT
[6]  
EBUBE NK, 1995, PHARM RES, V12, P144
[7]   APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT [J].
HUSSAIN, AS ;
YU, XQ ;
JOHNSON, RD .
PHARMACEUTICAL RESEARCH, 1991, 8 (10) :1248-1252
[8]   APPLICATION OF NEURAL COMPUTING IN PHARMACEUTICAL PRODUCT DEVELOPMENT - COMPUTER-AIDED FORMULATION DESIGN [J].
HUSSAIN, AS ;
SHIVANAND, P ;
JOHNSON, RD .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (10) :1739-1752
[9]  
KESAVAN JG, 1995, DISS ABSTR INT B, V56, P762
[10]  
MCCALL TW, 1994, PHARMACOL RES S, V11, P170